Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab’)2 fragments of an anti-tumour antibody

British Journal of Cancer

Volumn 71, Issue 1, 1995, Pages 18-24

  Marshall, D ^a   Pedley, R B ^a   Melton, R G ^b   Boden, J A ^a   Boden, R ^a   Begent, R H J ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Biotinylated antibodies; Clearance; Galactosylated streptavidin; Radioimmunotargeting

Indexed keywords

ANTIBODY; ASIALOFETUIN; ASIALOGLYCOPROTEIN RECEPTOR; BIOTIN; CANCER ANTIBODY; IMMUNOGLOBULIN F(AB')2 FRAGMENT; STREPTAVIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CIRCULATION; COLON CARCINOMA; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER CELL; LIVER CLEARANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RETICULOENDOTHELIAL SYSTEM; SPLEEN; TUMOR LOCALIZATION; XENOGRAFT;

ALPHA-FETOPROTEINS; ANTIBODIES, MONOCLONAL; ASIALOGLYCOPROTEIN RECEPTOR; ASIALOGLYCOPROTEINS; BACTERIAL PROTEINS; BIOTIN; CARCINOEMBRYONIC ANTIGEN; GALACTOSE; IMMUNOGLOBULINS, FAB; IODINE RADIOISOTOPES; METABOLIC CLEARANCE RATE; RADIOIMMUNODETECTION; RECEPTORS, CELL SURFACE; STREPTAVIDIN; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION;

EID: 0028891121     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.5     Document Type: Article

References (33)

1. ASH WELL G AND MORELL AG. (1974). The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv. Enzymol., 41, 99-128.
2. BAGSHAWE KD. (1987). Antibody directed enzymes revive anticancer prodrugs concept. Br. J. Cancer, 56, 531-532.
3. BENACERRAF B, SEBESTYEN M AND COOPER NS. (1959). The clearance of antigen antibody complexes from the blood by the reticulo-endothelial system. J. Immunol., 82, 131-137.
4. BEGENT RHJ, KEEP PA, GREEN AJ, SEARLE F, BAGSHAWE KD, JEWKES RF, JONES BE, BARRATT GM AND RYMAN BE. (1982). Liposomally entrapped second antibody improves tumour imaging with radiolabelled (first) antitumour antibody. Lancet, ii, 739–742.
5. BONFILS E, MENDES C, ROCHE A-C, MONSIGNY M AND MIDOUX P. (1992). Uptake by macrophages of a biotinylated oligo-a–deoxythymidylate by using mannosylated streptavidin. Bioconj. Chem., 3, 277-284.
6. DUBOIS M, GILLES KA, HAMILTON JK, REBERS PA AND SMITH F. (1956). Colorimetric method for determination of sugars and related substances. Anal. Chem., 28, 350-356.
7. FRAKER PJ AND SPECK JC. (1978). Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6–tetrachloro-3a, 6-diphenylglycoluril. Biochem. Biophys. Res. Commun., 80 (4), 849-857.
8. GREEN NM. (1965). A spectrophotometric assay for avidin and biotin based on binding of dyes by avidin. Bichem. J., 94, 23c-24c.
9. HARWOOD PJ, BODEN J, PEDLEY RB, RAWLINS G, ROGERS GT AND BAGSHAWE KD. (1985). Comparative tumour localization of antibody fragments and intact IgG in nude mice bearing a CEA-producing human colon tumour xenograft. Eur. J. Cancer Clin. Oncol., 21, 1515-1522.
10. KRANTZ MJ, HOLTZMAN NA, STOWELL CP AND LEE YC. (1976). Attachment of thioglycosides to proteins: enhancement of liver membrane binding. Biochemistry, 15, 3963-3968.
11. MARSHALL D, PEDLEY RB, BODEN JA, BODEN R AND BEGENT RHJ. (1994). Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model. Br. J. Cancer, 69, 502-507.
12. MATTES JM. (1987). Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications. J. Natl Cancer Inst., 79, 855-863.
13. OGIHARA-UMEDA I, SASAKI T, and NISHIGORI H. (1993). Active removal of radioactivity in the blood circulation using biotin–bearing liposomes and avidin for rapid tumour imaging. Eur. J. Nucl. Med., 29, 170-172.
14. OGIHARA-UMEDA I, SASAKI T, TOYAMA H, ODA K, SENDA M. and NISHIGORI H. (1994). Rapid tumor imaging by activie background reduction using biotin-bearing liposomes and avidin. Cancer Res., 54, 463-467.
15. PAGANELLI G, STELLA M, DE NARDI P, MAGNANI P, ZITO F, SICCARDI G, DI CARLO V AND FAZIO F. (1990a). A new method for faster blood clearance in radioimmuno-guided surgery. J. Nucl. Med. Allied. Sci., 35, 88-89.
16. PAGANELLI G, PERVEZ S, SICCARDI G, ROWLINSON G, DELEIDE G, CHIOLERIO F, MALCOVATI M, SCASSELLATI GG, and EPE-NETOS AA. (1990b). Intraperitoneal radio-localisation of tumours pre-targeted by biotinylated monoclonal antibodies. Int. J. Cancer, 45, 1184-1189.
17. PAGANELLI G, MAGNANI P, ZITO F, VILLA E, SUDATI F, LOPALCO L, ROSSETI L, MALCOVATI M, CHIOLERIO F, SECCAMANI E, SICCARDI AG AND FAZIO F. (1991). Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res., 51, 5960-5966.
18. PEDLEY RB, BODEN J, KEEP PA, HARWOOD PJ, GREEN AJ AND ROGERS GT. (1987). Relationship between tumour size and uptake of radiolabelled anti-CEA in a colonic tumour xenograft. Eur. J. Nucl. Med., 13, 197-202.
19. PEDLEY RB, DALE R, BODEN JA, BEGENT RHJ, KEEP PA AND GREEN AJ. (1989). The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti-CEA antibody in a human colonic tumour xenograft model. Int. J. Cancer, 43, 713-718.
20. 1311 anti-CEA antibody in a colonic xenograft model. Br. J. Cancer, 68, 69-73.
21. 2 fragments in human tumour xenografts: an autoradiographic and immunohistochemical study. Int. J. Cancer, Suppl. 3, 23-29.
22. RIFAI A, FINBLOOM DS, MAGILAVY DB AND PLOTZ PH. (1982). Modulation of the circulation and hepatic uptake of immune complexes by carbohydrate recognition systems. J. Immunol., 128, 2269-2275.
23. ROGERS JC AND KORNFELD S. (1971). Hepatic uptake of proteins coupled to fetuin glycopeptide. Biochem. Biophys. Res. Commun., 45, 622-629.
24. SAGA T, WEINSTEIN JN, JEONG JM, HEYA T, LEE JT, LE N, PAIK CH, SUNG C AND NEUMANN RD (1994). Two-step pretargeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin. Cancer Res., 54, 2160-2165.
25. SCHWARTZ AL. (1984). The hepatic asialoglycoprotein receptor. CRC Crit. Rev. Biochem., 16, 207-233.
26. SHARKEY RM, PRIMUS FJ AND GOLDENBERG DM. (1984). Second antibody clearance of radiolabeled antibody in cancer radiom–munodetection. Proc. Natl Acad. Sci. USA, 81, 2843– 2846.
27. SHARMA, SK, BAGSAHWE KD, BURKE PJ, BODEN RW AND ROGERS, GT. (1990). Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model. Br. J. Cancer, 61, 659-662.
28. SINITSYN W, MAMONTOVA AG, CHECKNEVA YY, SHNYRA AA AND DOMOGATSKY SP. (1989). Rapid blood clearance of biotinylated IgG after infusion of avidin. J. Nucl. Med., 30, 66–69.
29. THORNBERG RW, DAY JF, BAYNES JW AND THORPE SR. (1980). Carbohydrate-mediated clearance of immune complexes from the circulation. J. Biol. Chem., 255, 6820-6825.
30. TOM BH, RUTZKY LP, JAKSTYS MM, OYASU R, KAYE Cl and KAHAN BD. (1976). Human colonic adenocarcinoma cells. In Vitro, 12 (3), 180-191.
31. 2 fragment in nude mice bearing different human colon cancer xenografts. Br. J. Cancer, 68, 684-690.
32. YOKOTA T, MILENIC DE, WHITLOW M AND SCHLOM J. (1992). Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res., 52, 3402–3408.
33. YOKOTA T, MILENIC DE, WHITLOW M, WOOD JF, HUBERT SL AND SCHLOM J. (1993). Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. Cancer Res., 53, 3776-3783.